Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had a tissue biopsy confirming their diagnosis
- People whose cancer has not spread to the skin
- People whose cancer has spread to nearby lymph nodes, but only if those lymph nodes are limited to the groin and pelvis area
- People between the ages of 20 and 80
- People who are reasonably active and able to carry out daily activities (as measured by a standard medical scale called ECOG, scoring 0–2) (confirm with trial site)
- People who have no signs of cancer that has spread to distant parts of the body
- People whose cancer is at least 5 mm away from the rectum and bladder wall
- People who have not previously received radiation therapy
- People who are willing and able to give written consent to participate
- People who are able to understand what the trial involves and what it means for them
- People who have had molecular and genetic testing done on their cancer (confirm with trial site)
- People who have had standard tests done to determine the current stage of their disease
Who may not be able to join:
- People who have a hip replacement, metal implants, or any other condition that would prevent clear medical imaging needed to plan treatment
- People with psychological or other conditions that would prevent them from giving informed consent
- People who have previously had another cancer, unless they have been free of that cancer for at least 3 years
- People who are unable to have an MRI scan for any reason
- People who are currently pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Amelia Barcellini, MD, CNAO National Center of Oncological Hadrontherapy
Phone: 0039 0382078501
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
progression free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.